Clinical Trial Update: Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder [NA]

View source ↗

Summary

A clinical trial evaluating the combination of celecoxib and rosiglitazone for bladder cancer patients undergoing surveillance for early-stage noninvasive bladd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Avandia (rosiglitazone)
• CELEBREX (Celecoxib)

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Bladder Cancer | NA | Status: WITHDRAWN